{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:34:59Z","timestamp":1773250499683,"version":"3.50.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00788","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T05:05:19Z","timestamp":1590555919000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Protective Role of Enalapril in Anthracycline-Induced Cardiotoxicity: A Systematic Review"],"prefix":"10.3389","volume":"11","author":[{"given":"Yili","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nannan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangjia","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1186\/s12885-018-4935-z","article-title":"Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer","volume":"18","author":"Arciniegas Calle","year":"2018","journal-title":"BMC Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1590\/1806-9282.64.08.745","article-title":"Anthracycline-associated cardiotoxicity in adults: systematic review on the cardioprotective role of beta-blockers","volume":"64","author":"Barbosa","year":"2018","journal-title":"Rev. Assoc. Med. Bras."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/j.jacc.2013.02.072","article-title":"Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial","volume":"61","author":"Bosch","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/bjc.2013.788","article-title":"Subsequent hospitalisation experience of 5-year survivors of childhood, adolescent, and young adult cancer in Scotland: a population based, retrospective cohort study","volume":"110","author":"Brewster","year":"2014","journal-title":"Br. J. Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy\u2013induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation."},{"key":"B6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejca.2018.02.005","article-title":"Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial","volume":"94","author":"Cardinale","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12885-015-1407-6","article-title":"The prevention, detection and management of cancer treatment-induced cardiotoxicity: a meta-review","volume":"15","author":"Conway","year":"2015","journal-title":"BMC Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s00204-016-1759-y","article-title":"Pathways of cardiactoxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone","volume":"90","author":"Damiani","year":"2016","journal-title":"Arch. Toxicol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41371-018-0138-y","article-title":"A systematic review and network meta-analysis of the comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension","volume":"33","author":"Dimou","year":"2018","journal-title":"J. Hum. Hypertens"},{"key":"B10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12574-018-0394-4","article-title":"Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy","volume":"17","author":"El-Sherbeny","year":"2019","journal-title":"J. Echocardiogr."},{"key":"B11","unstructured":"London, United KingdomAssessment report. Dexrazoxane-containing medicinal products (EMEA\/H\/A-31\/1275).2019"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/ajh.21840","article-title":"Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up","volume":"85","author":"Georgakopoulos","year":"2010","journal-title":"Am. J. Hematol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27308","article-title":"Role of ACE inhibitors in anthracycline-induced cardiotoxicity: A randomized, double-blind, placebo-controlled trial","volume":"65","author":"Gupta","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"B15","first-page":"214","article-title":"HIF-1\u03b1 and paradoxical phenomena in cardioprotection","volume-title":"Cardiovasc. Res.","author":"Heusch","year":"2012"},{"key":"B16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12012-016-9365-z","article-title":"Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy","volume":"17","author":"Janbabai","year":"2017","journal-title":"Cardiovasc. Toxicol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-007842","article-title":"The efficacy and safety of complete pericardial drainage by means of intrapericardial fibrinolysis for the prevention of complications of pericardial effusion: a systematic review protocol","volume":"1","author":"Kakia","year":"2016","journal-title":"BMJ Open"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1016\/j.ijcard.2012.06.023","article-title":"Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study","volume":"167","author":"Kaya","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00109-017-1569-6","article-title":"The promise of stromal cell-derived factor-1 in novel heart disease treatments","volume":"95","author":"Luft","year":"2017","journal-title":"J. Mol. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jcmg.2017.11.017","article-title":"Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction","volume":"11","author":"Potter","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"B21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.18632\/oncotarget.22946","article-title":"Molecular mechanisms of cardioprotective effects mediated by transplanted cardiac ckit+ cells through the activation of an inflammatory hypoxia-dependent reparative response","volume":"9","author":"Puddighinu","year":"2018","journal-title":"Oncotarget."},{"key":"B22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Rebecca","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"B23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/HCO.0000000000000637","article-title":"Cardiotoxicity of HER2-targeted therapies","volume":"34","author":"Robert","year":"2019","journal-title":"Curr. Opin. Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cjca.2016.01.027","article-title":"Mechanisms of cardiotoxicity of cancer chemotherapeutic agents: Cardiomyopathy and beyond","volume":"32","author":"Rohit","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/leu.2009.261","article-title":"Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children\u2019s oncology group","volume":"24","author":"Salzer","year":"2010","journal-title":"Leukemia."},{"key":"B26","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1200\/JCO.2004.06.022","article-title":"Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines","volume":"22","author":"Silber","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.toxlet.2019.02.013","article-title":"Oxidative stress injury in doxorubicin-induced cardiotoxicity","volume":"307","author":"Songbo","year":"2019","journal-title":"Toxicol. Lett."},{"key":"B28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1200\/JCO.2005.02.3879","article-title":"Dexrazoxane-associated risk for acute myeloid leukemia\/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin\u2019s disease","volume":"25","author":"Tebbi","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108637","article-title":"Attenuation of doxorubicin-induced cardiotoxicity in a human in vitro cardiac model by the induction of the NRF-2 pathway","volume":"112","author":"Tomlinson","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212907","article-title":"Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis","volume":"14","author":"Turgeon","year":"2019","journal-title":"PloS One"},{"key":"B31","first-page":"20","article-title":"SDF-1\u03b1 and CXCR4 as therapeutic targets in cardiovascular disease","volume":"2","author":"Wen","year":"2012","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.18203\/2349-3933.ijam20180061","article-title":"Protective effect of carvedilol against anthracycline-induced cardiomyopathy on patients with breast cancer and lymphoma","volume":"5","author":"Zamani","year":"2018","journal-title":"Int. J. Adv. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"A32","DOI":"10.1136\/hrt.2010.208967.98","article-title":"e0098 HIF-1\u03b1, SDF-1\u03b1 and VEGF gene expression affected by HIF-1\u03b1 siRNA in MSCs","volume":"96","author":"Zhang","year":"2010","journal-title":"Heart."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00788\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T05:05:23Z","timestamp":1590555923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00788\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":33,"alternative-id":["10.3389\/fphar.2020.00788"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00788","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"article-number":"788"}}